4 Basebio Ag Na O.N EBITDA margin

¿Qué es el EBITDA margin de 4 Basebio Ag Na O.N?

El EBITDA margin de 4 Basebio Ag Na O.N. es 75.98%

¿Cuál es la definición de EBITDA margin?



EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.

ttm (trailing twelve months)

EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.

EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.

EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.

EBITDA margin de compañías en Sector Health Care en XETRA en comparadas con 4 Basebio Ag Na O.N

¿Qué hace 4 Basebio Ag Na O.N?

2invest AG, an investment company, acquires, holds, manages, and sells investments in corporations and partnerships primarily in the biotechnology, life science, and IT sectors in Germany and internationally. The company was formerly known as 4basebio AG and changed its name to 2invest AG in January 2021. 2invest AG is based in Heidelberg, Germany.

Empresas con ebitda margin similar a 4 Basebio Ag Na O.N